ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
Dow Jones
42.732,13
0,80%
Euro vs US Dollar
1,03125
0,00%
Bitcoin
98.048,12
-0,06%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Evaxion Biotech AS (EVAX) Börsenkurse

Evaxion Biotech AS

Evaxion Biotech AS (EVAX)

NASDAQ
0,91
-0,01427
(-1,54%)
Geschlossen 04 Januar 10:00PM
Verzögert um 15 Minuten
0,912
0,002
(0,22%)
Nach Börsenschluss: 1:42AM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,912
Gebot
0,912
Fragen
0,93
Volumen
155.523
0,8703 Tagesbereich 0,938
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
5,089M
Handelsende
0,924268
Handelsbeginn
0,92
Letzte Trade
84
@
0.912
Letzter Handelszeitpunkt
Finanzvolumen
US$ 141.400
VWAP
0,909187
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
5.580.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
507k
Nettogewinn
-152,41M

Über Evaxion Biotech AS

Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in... Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market. Its two lead product candidates are EVX-01 and EVX-02, for the treatment of various cancers. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.evaxion-biotech.com
Hauptsitz
Horsholm, Dnk
Gegründet
-
Evaxion Biotech AS is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker EVAX. The last closing price for Evaxion Biotech AS was US$0,92. Over the last year, Evaxion Biotech AS shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Evaxion Biotech AS currently has 5.580.000 shares in issue. The market capitalisation of Evaxion Biotech AS is US$5,16 million.

EVAX Neueste Nachrichten

Weitere Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

30 Dezember 2024
Edgar (US Regulatory)

Evaxion announces plan to implement ADS ratio change

COPENHAGEN, Denmark, December 30, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today...

30 Dezember 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 Dezember 2024
Edgar (US Regulatory)

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

17 Dezember 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Dezember 2024
Edgar (US Regulatory)

Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity

Evaxion and the European Investment Bank (EIB) are in advanced discussions about conversion of €3.5 million out of Evaxion’s €7 million loan with EIB into an equity-type instrumentSuch conversion...

17 Dezember 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 Dezember 2024
Edgar (US Regulatory)

Evaxion establishes new AI-derived precision cancer vaccine concept

Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across patientsNovel preclinical data confirms the...

12 Dezember 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

09 Dezember 2024
Edgar (US Regulatory)

Evaxion announces 2025 milestones reflecting continued strong strategy execution

With most of Evaxion’s strategic milestones for 2024 now successfully achieved, the company announces milestones for 2025The 2025 key milestones reflect all parts of Evaxion’s strategy for value...

09 Dezember 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

EVAX - Frequently Asked Questions (FAQ)

What is the current Evaxion Biotech AS share price?
The current share price of Evaxion Biotech AS is US$ 0,912
How many Evaxion Biotech AS shares are in issue?
Evaxion Biotech AS has 5.580.000 shares in issue
What is the market cap of Evaxion Biotech AS?
The market capitalisation of Evaxion Biotech AS is USD 5,16M
What is the 1 year trading range for Evaxion Biotech AS share price?
Evaxion Biotech AS has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Evaxion Biotech AS?
Evaxion Biotech AS reports financial results in USD
What is the latest annual turnover for Evaxion Biotech AS?
The latest annual turnover of Evaxion Biotech AS is USD 507k
What is the latest annual profit for Evaxion Biotech AS?
The latest annual profit of Evaxion Biotech AS is USD -152,41M
What is the registered address of Evaxion Biotech AS?
The registered address for Evaxion Biotech AS is DR. NEERGAARDS VEJ 5F, HORSHOLM, 2970
What is the Evaxion Biotech AS website address?
The website address for Evaxion Biotech AS is www.evaxion-biotech.com
Which industry sector does Evaxion Biotech AS operate in?
Evaxion Biotech AS operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
259,75M
NITON2OFF Inc
US$ 2,6306
(145,85%)
350,87M
CRNCCerence Inc
US$ 19,33
(143,76%)
159,55M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,76M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,52M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,08M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,62M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
155,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
965,65k
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,4M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,26M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,49M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,58M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,91M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
EVAX
Evaxion Biotech AS
AQSE
WHEA.GB
State Street Global Advi...
BIT
P1IBD6
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten